Siegfried Holding AG

SFZN

Company Profile

  • Business description

    Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.

  • Contact

    Untere Bruehlstrasse 4
    ZofingenCH-4800
    CHE

    T: +41 627461111

    E: [email protected]

    https://www.siegfried.ch

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    3,891

Stocks News & Analysis

stocks

Cheap Dividend Aristocrat has Fair Value raised after earnings

Dividend forecasts raised after balance sheet regains strength.
stocks

Why great earnings haven't been good enough for AI hardware stocks

Stocks that had been posting triple-digit returns are sliding on earnings results.
stocks

Fair Value increased for Big 4 bank after earnings

Shares still overvalued, with analysts thinking the fundamentals no longer matter to the share price.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,313.2019.60-0.21%
CAC 408,636.8013.76-0.16%
DAX 4026,440.31140.570.53%
Dow JONES (US)53,732.41107.58-0.20%
FTSE 10010,750.1122.56-0.21%
HKSE25,116.85279.66-1.10%
NASDAQ26,729.1673.86-0.28%
Nikkei 22568,713.80405.200.59%
NZX 50 Index13,854.3829.080.21%
S&P 5007,785.7613.23-0.17%
S&P/ASX 2009,115.2019.90-0.22%
SSE Composite Index3,927.180.210.01%

Market Movers